• 1
    Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatr Blood Cancer 2005; 44:4618.
  • 2
    Torelli GF, Lucarelli B, Iori AP et al. The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection. Leuk Res 2011; 35:11246.
  • 3
    Storek J, Geddes M, Khan F et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008; 30:42537.
  • 4
    Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2008; 21:57996.
  • 5
    Sahdev I, O'Reilly R, Black P, Heller G, Hoffmann M. Interleukin-1 production following T-cell-depleted and unmodified marrow grafts. Pediatr Hematol Oncol 1996; 13:5567.
  • 6
    Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991; 77:3939.
  • 7
    Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, Wodnar-Filipowicz A. Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. Blood 2004; 103:38608.
  • 8
    Collin MP, Hart DNJ, Jackson GH et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006; 203:2733.
  • 9
    Gratama JW, Naipal A, Oljans P et al. T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host disease. Blood 1984; 63:141623.
  • 10
    Dumont-Girard F, Roux E, van Lier RA et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998; 92:446471.
  • 11
    van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Khan PM, Vossen JM. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 1993; 82:19218.
  • 12
    Chalandon Y, Degermann S, Villard J et al. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 2006; 107:38996.
  • 13
    Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein–Barr virus after allogeneic bone marrow transplantation. Blood 1996; 87:2594603.
  • 14
    Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78:137380.
  • 15
    Rufer N, Helg C, Chapuis B, Roosnek E. Human memory T cells: lessons from stem cell transplantation. Trends Immunol 2001; 22:13641.
  • 16
    Cavazzana-Calvo M, André-Schmutz I, Dal Cortivo L, Neven B, Hacein-Bey-Abina S, Fischer A. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress. Curr Opin Immunol 2009; 21:5448.
  • 17
    Baumgartner C, Morell A, Hirt A et al. Humoral immune function in pediatric patients treated with autologous bone marrow transplantation for B cell non-Hodgkin's lymphoma. The influence of ex vivo marrow decontamination with anti-Y 29/55 monoclonal antibody and complement. Blood 1988; 71:121117.
  • 18
    Gokmen E, Raaphorst FM, Boldt DH, Teale JM. Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization. Blood 1998; 92:280214.
  • 19
    Omazic B, Lundkvist I, Mattsson J, Permert J, Nasman-Bjork I. Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation. Clin Exp Immunol 2003; 134:15966.
  • 20
    Avanzini MA, Locatelli F, Dos Santos C et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005; 33:4806.
  • 21
    Storek J, Witherspoon RP, Storb R. Reconstitution of membrane IgD− (mIgD–) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells. Blood 1997; 89:3501.
  • 22
    Suzuki I, Milner EC, Glas AM et al. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 1996; 87:187380.
  • 23
    Lausen BF, Hougs L, Schejbel L, Heilmann C, Barington T. Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient. J Immunol 2004; 172:330518.
  • 24
    Wimperis JZ, Gottlieb D, Duncombe AS, Heslop HE, Prentice HG, Brenner MK. Requirements for the adoptive transfer of antibody responses to a priming antigen in man. J Immunol 1990; 144:5417.
  • 25
    Auffermann-Gretzinger S, Lossos IS, Vayntrub TA et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99:14428.
  • 26
    Bengtsson M, Smedmyr B, Festin R, Oberg G, Simonsson B, Tötterman TH. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers. Leuk Res 1989; 13:7917.
  • 27
    Pedrazzini A, Freedman AS, Andersen J et al. Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. Blood 1989; 74:220311.
  • 28
    Okudaira H, Ishizaka K. Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation. Cell Immunol 1981; 58:188201.
  • 29
    Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8:36372.
  • 30
    van Tol MJ, Gerritsen EJ, de Lange GG et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996; 87:81826.
  • 31
    Auletta JJ, Cooke KR. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 2009; 21:308.
  • 32
    Wingard JR, Majhail NS, Brazauskas R et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29:22309.
  • 33
    Popat U, Carrum G, Heslop HE. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 29:310.
  • 34
    Tomblyn M, Chiller T, Einsele H et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009; 44:453558.
  • 35
    Atkinson K, Storb R, Prentice RL et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53:72031.
  • 36
    Engelhard D, Cordonnier C, Shaw PJ et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117:44450.
  • 37
    Winston DJ, Schiffman G, Wang DC et al. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 1979; 91:83541.
  • 38
    Kruetzmann S, Rosado MM, Weber H et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197:93945.
  • 39
    Storek J, Joseph A, Espino G et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001; 98:350512.
  • 40
    Cohen S, Freeman T. Metabolic heterogeneity of human gamma-globulin. Biochem J 1960; 76:47587.
  • 41
    Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162:496500.
  • 42
    Wahren B, Gahrton G, Linde A et al. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150:35865.
  • 43
    Ahuja A, Anderson SM, Khalil A, Shlomchik MJ. Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci USA 2008; 105:48027.
  • 44
    Auletta JJ, Cooke KR, Solchaga LA, Deans RJ, van't Hof W. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions. Biol Blood Marrow Transplant 2010; 16:891906.
  • 45
    Chu VT, Fröhlich A, Steinhauser G et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 2011; 12:1519.
  • 46
    Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199202.
  • 47
    Gray D. A role for antigen in the maintenance of immunological memory. Nat Rev Immunol 2002; 2:605.
  • 48
    Lycke N, Bemark M. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins. Mucosal Immunol 2010; 3:55666.
  • 49
    Witherspoon RP, Kopecky K, Storb RF et al. Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. Transplantation 1982; 33:1439.
  • 50
    Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986; 154:5906.
  • 51
    Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992; 88:5129.
  • 52
    Lutz E, Ward KN, Szydlo R, Goldman JM. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status. J Med Virol 1996; 49:615.
  • 53
    Tomblyn M, Chiller T, Einsele H et al. Guidelines for preventing infectious complications amonghematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143238.
  • 54
    Hallstrand TS, Sprenger JD, Agosti JM, Longton GM, Witherspoon RP, Henderson WR Jr. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 2004; 104:308690.
  • 55
    Gerritsen EJ, van Tol MJ, Lankester AC et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82:3493502.
  • 56
    Aucouturier P, Barra A, Intrator L et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:77985.
  • 57
    Lum LG, Seigneuret MC, Orcutt-Thordarson N, Noges JE, Storb R. The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation: VI. differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting. Blood 1985; 65:142233.
  • 58
    Korsmeyer SJ, Elfenbein GJ, Goldman CK, Marshall SL, Santos GW, Waldmann TA. B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation 1982; 33:18490.
  • 59
    Keightley RG, Cooper MD, Lawton AR. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol 1976; 117:153844.
  • 60
    Kirchner H, Tosato G, Blaese RM, Broder S, Magrath IT. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein–Barr virus in vitro. J Immunol 1979; 122:13103.
  • 61
    Dilly SA, Sloane JP. Cellular composition of the spleen after human allogeneic bone marrow transplantation. J Pathol 1988; 155:15160.
  • 62
    Sale GE, Alavaikko M, Schaefers KM, Mahan CT. Abnormal CD4 : CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): an immunohistological study. Exp Hematol 1992; 20:101721.
  • 63
    Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008; 20:14957.
  • 64
    Jackson SM, Wilson PC, James JA, Capra JD. Human B cell subsets. Adv Immunol 2008; 98:151224.
  • 65
    Carsetti R, Köhler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995; 181:212940.
  • 66
    Cuss AK, Avery DT, Cannons JL et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006; 176:150616.
  • 67
    Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005; 105:43908.
  • 68
    Lee J, Kuchen S, Fischer R, Chang S, Lipsky PE. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 2009; 182:411626.
  • 69
    Suryani S, Fulcher DA, Santner-Nanan B et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 2010; 115:51929.
  • 70
    Andrews S, Wilson P. The anergic B cell. Blood 2010; 115:4976.
  • 71
    Wirths S, Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 2005; 35:343341.
  • 72
    Palanichamy A, Barnard J, Zheng B et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 2009; 182:598293.
  • 73
    Klein U, Rajewsky K, Küppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188:167989.
  • 74
    Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol 2010; 11:6818.
  • 75
    Bemark M, Bergqvist P, Stensson A, Holmberg A, Mattsson J, Lycke NY. A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development. J Immunol 2011; 186:1399410.
  • 76
    Seifert M, Küppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 2009; 206:265969.
  • 77
    Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or ‘memory’ B cells? J Immunol 2007; 179:1319.
  • 78
    Weill J-C, Weller S, Reynaud C-A. Human marginal zone B cells. Annu Rev Immunol 2009; 27:26785.
  • 79
    Wu Y-C, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 2010; 116:10708.
  • 80
    Fecteau JF, Côté G, Néron S. A new memory CD27–IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006; 177:372836.
  • 81
    Koethe S, Zander L, Koster S et al. Pivotal advance: CD45RB glycosylation is specifically regulated during human peripheral B cell differentiation. J Leukoc Biol 2011; 90:519.
  • 82
    Wrammert J, Smith K, Miller J et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:66771.
  • 83
    Ghosn EEB, Sadate-Ngatchou P, Yang Y, Herzenberg LA, Herzenberg LA. Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen. Proc Natl Acad Sci USA 2011; 108:287984.
  • 84
    Weller S, Braun MC, Tan BK et al. Human blood IgM ‘memory’ B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:364754.
  • 85
    Weller S, Mamani-Matsuda M, Picard C et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 2008; 205:133142.
  • 86
    Kubicka U, Olszewski WL, Tarnowski W, Bielecki K, Ziolkowska A, Wierzbicki Z. Normal human immune peritoneal cells: subpopulations and functional characteristics. Scand J Immunol 1996; 44:15763.
  • 87
    Donze HH, Lue C, Julian BA, Kutteh WH, Kantele A, Mestecky J. Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels. Clin Exp Immunol 1997; 109:35661.
  • 88
    Boursier L, Farstad IN, Mellembakken JR, Brandtzaeg P, Spencer J. IgVH gene analysis suggests that peritoneal B cells do not contribute to the gut immune system in man. Eur J Immunol 2002; 32:242736.
  • 89
    Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70–. J Exp Med 2011; 208:6780.
  • 90
    Horgan KJ, Tanaka Y, Luce GE, van Seventer GA, Nutman TB, Shaw S. CD45RB expression defines two interconvertible subsets of human CD4+ T cells with memory function. Eur J Immunol 1994; 24:12403.
  • 91
    Corre E, Carmagnat M, Busson M et al. Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica 2010; 95:10259.
  • 92
    D'Orsogna LJ, Wright MP, Krueger RG et al. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells. Biol Blood Marrow Transplant 2009; 15:795803.
  • 93
    Greinix HT, Pohlreich D, Kouba M et al. Elevated numbers of immature/transitional CD21− B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14:20819.
  • 94
    Sarantopoulos S, Stevenson KE, Kim HT et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 2009; 113:386574.
  • 95
    Marie-Cardine A, Divay F, Dutot I et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008; 127:1425.
  • 96
    Antin JH, Ault KA, Rappeport JM, Smith BR. B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes. J Clin Invest 1987; 80:32532.
  • 97
    Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76:164756.
  • 98
    Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12:38798.
  • 99
    Velardi A, Cucciaioni S, Terenzi A et al. Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. J Immunol 1988; 141:81520.
  • 100
    Elfenbein GJ, Bellis MM, Ravlin HM, Santos GW. Phenotypically immature B mu cells in the peripheral blood after bone marrow grafting in man. Exp Hematol 1982; 10:5519.
  • 101
    Ault KA, Antin JH, Ginsburg D et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161:1483502.
  • 102
    Parra C, Roldán E, Brieva JA. Deficient expression of adhesion molecules by human CD5− B lymphocytes both after bone marrow transplantation and during normal ontogeny. Blood 1996; 88:173340.
  • 103
    Kagan JM, Champlin RE, Saxon A. B-cell dysfunction following human bone marrow transplantation: functional–phenotypic dissociation in the early posttransplant period. Blood 1989; 74:77785.
  • 104
    Eyrich M, Leiler C, Lang P et al. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003; 32:37990.
  • 105
    Uckun FM, Haissig S, Ledbetter JA et al. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein. Blood 1992; 79:336979.
  • 106
    Koehne G, Zeller W, Stockschlaeder M, Zander AR. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19:14956.